Cholecystokinin: Role in thermoregulation and other aspects of energetics

Clinica Chimica Acta

Volumn 411, Issue 5-6, 2010, Pages 329-335

  Szelényi, Zoltán ^a,b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

CCK; CCK1 and CCK2 receptor; Fever; Hyperthermia; Hypothermia; Satiety

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; PROTEIN C FOS;

CORE TEMPERATURE; ENERGY TRANSFER; FEVER; FOOD INTAKE; GENE FUNCTION; HEAT LOSS; HYPOTHERMIA; METABOLIC RATE; NEUROTRANSMISSION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THERMOGENESIS; THERMOREGULATION;

BODY TEMPERATURE; CHOLECYSTOKININ; ENERGY METABOLISM; HUMANS;

RATTUS; RODENTIA;

EID: 74849112328     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.12.016     Document Type: Review

References (80)

1. Gibbs J., Young R., and Smith G.P. Cholecystokinin decreases food intake in rats. J Comp Physiol 84 (1973) 488-493
2. Larsson L.I., and Rehfel J.F. Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res 165 (1979) 210-218
3. Beinfeld M.C., and Palkovits M. Distribution of cholecystokinin (CCK) in the hypothalamus and limbic system of the rat. Neuropeptides 2 (1981) 123-129
4. Day N.C., Hall M.D., Clark C.R., and Hughes J. High concentration of cholecystokinin receptor binding sites in the ventromedial hypothalamic nucleus. Neuropeptides 8 (1986) 1-18
5. Székely M., and Szelényi Z. Regulation of energy balance by peptides: a review. Curr Prot Pept Sci 6 (2005) 327-353
6. Della-Fera M.A., and Baile C.A. Cholecystokinin octapeptide: continuous picomole injections into the cerebral ventricles of sheep suppress feeding. Science 206 (1979) 471-473
7. Shiraishi T. CCK as a central satiety factor: behavioral and electrophysiological evidence. Physiol Behav 48 (1990) 879-885
8. Moran T.H., and Kinzig K.P. Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol 286 (2004) G183-G188
9. Smith G.P. Cholecystokinin and treatment of meal size: proof of principle. Obes Res 14 (2006) S168-S170
10. Donovan M.J., Paulino G., and Raybound H.E. CCK1 receptor is essention for normal meal patterning in mice fed a high fat diet. Physiol Behav 92 (2007) 969-974
11. Bi S., Chen J., Belles R.R., Hyun J., Kopin A.S., and Moran T.H. Differential body weight and feeeding response to high fat diets in rats and mice lacking cholecystokinin 1 receptor. Am J Physiol 283 (2007) R55-R63
12. Moran T.H. Unraveling the obesity of OLETF rats. Physiol Behav 94 (2008) 71-78
13. Clerc P., Coll Constans M.G., Lulka H., et al. Involvement of CCK2 receptor in food intake regulation: hyperphagia and increased fat deposition in CCK2 receptor-deficient mice. Endocrinology 148 (2007) 1039-1049
14. Chen H., Kent S., and Morris M.J. Is the CCK2 receptor essential for normal regulation of body weight and adiposity?. Eur J NeuroSci 24 (2006) 1427-1433
15. Gordon C.J. Temperature regulation in laboratory rodents (1993), Cambridge University Press
16. Lo C.-M., Samuelson L.C., Chambers J.B., et al. Characterization of mice lacking the gene for cholecystokinin. Am J Physiol 294 (2008) R803-R810
17. Nomoto S., Ohta M., Kanai S., et al. Absence of the cholecystokinin-A receptor deteriorates homeostasis of body temperature in response to changes in ambient temperature. Am J Physiol 287 (2004) R556-R561
18. Sei M., Sei H., and Shima K. Spontaneous activity, sleep, and body temperature in rats lacking the CCK-A receptor. Physiol Behav 68 (1999) 25-29
19. Ivanov A.I., Kulchitsky V.A., and Romanovsky A.A. Role of cholecystokinin-A receptor in fever: a study of a mutant rat strain and pharmacological analysis. J Physiol 547 (2003) 941-949
20. Weiland T.J., Voudouris N.J., and Kent S. The role of CCK2 receptors in energy homeostasis: Insights from the CCK2 receptor-deficient mouse. Physiol Behav 82 (2004) 471-476
21. Morley J.E., Levine A.S., and Lindblad S. Intraventricular cholecystokinin-octapeptide produces hypothermia in rats. Eur J Pharmacol 74 (1981) 249-251
22. Clark W.G., and Lipton J.M. Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents: II. Neurosci Biobehav Rev 9 (1985) 299-371
23. Zadina J.E., Banks W.A., and Kastin A.J. Central nervous system effects of peptides. 1980-85: a cross-listing of peptides and their central actions from the first six years of the journal Peptides. Peptides 7 (1986) 497-537
24. Kaatsura G., and Itoh S. Effect of cholecystokinin octapeptide on body temperature in the rat. Jap J Physiol 31 (1981) 849-858
25. Kapas L.F., Obal Jr. F., Alföldi P., Rubicsek Gy., Penke B., and Obal F. Effects of nocturnal intraperitoneal administration of cholecystokinin in rats: simultaneous increase in sleep, increase in EEG slow-wave activity, reduction of motor activity, supression of eating, and decrease in brain temperature. Brain Res 438 (1988) 155-164
26. Kapas L., Benedek G., and Penke B. Cholecystokinin interferes with the thermoregulatory effect of exogenous and endogenous opioids. Neuropeptides 14 (1991) 85-92
27. Liu H.J., and Lin M.T. Cholecystokinin-induced hypothermia: possible involvement of serotoninergic mechanisms in the rat hypothalamus. Pharmacology 31 (1985) 108-114
28. Shian L.R., and Lin M.T. Effects of cholecystokinin octapeptide on thermoregulatory responses and hypothalamic neuronal activity in the rat. Nauny-Schmiedebergs Arch Pharmacol 328 (1985) 363-367
29. Zetler G. Cholecystokinin octapeptide, caerulein and caerulein analogues: effects on thermoregulation in the mouse. Neuropharmacology 21 (1982) 795-801
30. Savory C.J. Alternative explanation for apparent satiety properties of peripherally administered bombesin and CCK in domestic fowls. Physiol Behav 39 (1987) 191-212
31. Passaro E., Debas H., Oldendorf W., and Yamada T. Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation. Brain Res 241 (1982) 338-340
32. Curry S.H., McCarthy D., Morris C.F., and Simpson-Heren L. Whole body autoradiography of CCK-8 in rats. Regul Pept 55 (1995) 179-188
33. Zhu X.G., Greely Jr. G.H., Lewis G., Lilja P., and Thompson J.C. Blood-CSF barrier to CCK and effect of centrally administered bombesin on release of brain CCK. Neurosci Res 15 (1986) 393-503
34. Moran T.H., Ameglio P.J., Schwartz G.J., and McHugh P.R. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am J Physiol 262 (1992) R46-R50
35. Szelényi Z., Barthó L., Székely M., and Romanovsky A.A. Cholecystokinin octapeptide (CCK-8) injected into a cerebral ventricle induces a fever-like thermoregulatory response mediated by type B CCK-receptors in the rat. Brain Res 638 (1994) 69-77
36. Rezayat M., Ravandeh N., and Zarrindast M.R. Cholecystokinin and morphine-induced hypothermia. Eur J Neuropharmacol 9 (1999) 219-225
37. Pullen R.G.L., and Hodgson O.J. Penetration of diazepam and the non-peptide CCK-antagonist, L364718 into the brain. J Pharm Pharmacol 39 (1987) 863-864
38. Woltman T.A., Hulce M., and Reidelberger R.D. Relative blood-brain barrier permeabilities of the cholecystokinin antagonist devazepide and A-65186 in rats. J Pharm Pharmacol 51 (1999) 917-920
39. Palkovits M., Kiss J.Z., Beinfeld M.C., and Williams T.H. Cholecystokinin in the nucleus of the solitary tract of the rat: evidence for its vagal origin. Brain Res 252 (1982) 386-390
40. Chang H.Y., and Kapás L. Selective activation of CCK-B receptors does not induce sleep and does not affect EEG slow-wave activity and brain temperature in rats. Physiol Behav 62 (1997) 175-179
41. Kandasamy S.B., and Williams B.A. Cholecystokinin-octapeptide-induced hyperthermia in guinea-pigs. Experientia 39 (1983) 1282-1284
42. Denbow D.M., and Myers R.D. Eating, drinking and temperature responses to intracerebroventricular cholecystokinin in the chick. Peptides 3 (1982) 739-743
43. Sakatani N., Inui A., Inoue T., Oya M., Morioka H., and Baba S. The role of cholecystokinin octapeptide in the central control of food intake in the dog. Peptides 8 (1987) 651-656
44. DeMesquita S., and Haney W.H. Effect of chronic intracerebroventricular infusion of cholecystokinin on respiration and sleep. Brain Res 378 (1986) 127-323
45. Yoshimatsu H., Egawa M., and Bray G.A. Effects of cholecystokinin on sympathetic activity to interscapular brown adipose tissue. Brain Res 597 (1992) 298-303
46. Székely M., Szelényi Z., and Sümegi I. Brown adipose tissue as a source of heat during pyrogen-induced fever. Acta Physiol Hung 43 (1973) 85-88
47. Székely M., Szelényi Z., and Balaskó M. Cholecystokinin participates in the mediation of fever. Pflügers Arch 428 (1994) 671-673
48. Ghosh S., Geller E.B., and Adler M.W. Interaction of cholecystokinin and somatostatin with a μ-opioid agonist and μ- and κ-antagonist in thermoregulation. Brain Res 745 (1997) 152-157
49. Ghosh S., Handler C.M., Geller E.B., and Adler M.W. Effect of μ-selective opioid antagonist on CCK-8-induced changes in thermoregulation in the rat. Pharmacol Biochem Behav 59 (1998) 261-264
50. Shido O., Yoneda Y., and Nagasaka T. Changes in brown adipose tissue metabolism following intraventricular vasoactive intestinal peptide and other gastrointestinal peptides in rats. Jpn J Physiol 39 (1989) 359-369
51. Sugimoto N., Simons C.T., and Romanovsky A.A. Vagotomy does not affect thermal responsiveness to intrabrain prostaglandin E2 and cholecystokinin octapeptide. Brain Res 844 (1999) 157-163
52. Szelényi Z., Hummel Z., Székely M., and Pétervári E. CCK-8 and PGE1: central effects on circadian body temperature and activity in rats. Physiol Behav 81 (2004) 615-621
53. Fukagawa K., Sakata T., Yoshimatsu H., Fujimoto K., Uchimura K., and Asano C. Advance shift of feeding circadian rhythm induced by obesity progression in Zucker rats. Am J Physiol 263 (1992) R1169-R1175
54. Hart B.L. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12 (1988) 123-137
55. Szelényi Z., and Székely M. Sickness behavior in fever and hypothermia. Front Biosci 9 (2004) 2447-2456
56. Shido O., Sakurada S., Kohda W., and Nagasaka T. Day-night changes of body temperature and feeding activity in heat-activated rats. Physiol Behav 55 (1994) 935-939
57. Martin S.M., Wilson B.C., Chen X., Takahashi Y., Poulin P., and Pittman Q.J. Vagal CCK and 5-HT3 receptors are unlikely to mediate LPS or IL-1β-induced fever. Am J Physiol 279 (2000) R960-R965
58. Bret-Dibat J.-L., and Dantzer R. Cholecystokinin receptors do not mediate the suppression of food-motivated behavior by lipopolysaccharide and interleukin-1 beta in mice. Physiol Behav 69 (2000) 325-331
59. Daun J.M., and McCarthy D.O. The role of cholecystokinin in interleukin-1 induced anorexia. Physiol Behav 54 (1993) 237-241
60. Bluthé R.M., Michaud B., Kelley K.A., and Dantzer R. Cholecystokin receptors do not mediate the behavioral effects of lipopolysaccharide in mice. Physiol Behav 62 (1997) 385-389
61. Weiland T.J., Voudouris N.J., and Kent S. CCK2 receptor nullification attenuates lipopolysaccharide-induced sickness behavior. Am J Physiol 292 (2007) R112-R123
62. Blevins J.E., Hamel F.G., Fairbairm E., Stanley B.G., and Reidelberg R.D. Effects of paraventricular nucleus injection of CCK-8 on plasma CCK-8 levels in rats. Brain Res 860 (2000) 11-20
63. Auernhammer C.J., Riepl R.L., Schopohl J., Lehnert P., Müller O.A., and Stalla G.K. In man μ-opiate agonist loperamide specifically inhibits ACTH secretion induced by the cholecystokinin-like peptide ceruletide. Neuroendocrinology 60 (1994) 16-22
64. Raud S., Innos J., Abramov U., Reimets A., et al. Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test. Psychopharmacology (Berl) 181 (2005) 347-357
65. Daugé V., Sebret A., Beslot F., Matsui T., and Roques B.P. Behavioral profile of CCK2 receptor-deficient mice. Neuropsychopharmacology 25 (2001) 690-698
66. Ohgo S., Nakatsura K., Ishikawa E., and Matsukura S. Stimulation of cholecystokinin (CCK) release from superfused rat hypothalamo-neurohypophyseal complexes by interleukin-1 (IL-1). Brain Res 593 (1992) 25-31
67. Day H.E., and Akil H. Evidence that cholecystokinin receptors are not involved in the hypotalamo-pituitary-adrenal response to intraperitoneal administration of interleukin-1beta. J Neuroendocrinol 11 (1999) 561-568
68. Bhatnagar S., Viau V., Chu A., Soriano L., Meijer O.C., and Dallman M.F. Cholecystokinin-mediated pathway to the paraventricular thalamus is recruited in chronically stressed rats and regulates hypothalamic-pituitary-adrenal function. J Neurosci 20 (2000) 5564-5573
69. Siegel R.A., Duker E.M., Pahnke U., and Wuttke W. Stress-induced changes in cholecystokinin and substance P concentrations in discrete regions of the rat hypothalamus. Neuroendocrinology 46 (1987) 75-81
70. Szelényi Z., Székely M., and Balaskó M. Role of substance-P (SP) in the mediation of endotoxin (LPS) fever in rats. Ann NY Acad Sci 813 (1997) 316-323
71. South E.H. Cholecysokinin reduces body temperature in vehicle - but not capsaicin-treated rats. Am J Physiol (1992) R1215-R1221
72. Chen D.-Y., Deutsch J.A., Gonzalez M.F., and Gu Y. The induction and suppression of c-fos expression in the rat brain by cholecystokinin and its antagonist L-364, 718. Neurosci Let 149 (1993) 91-94
73. Noetzel S., Stengel A., Infoff T., et al. CCK-8S activates c-fos in a dose-dependent manner in nesfatin-1 immunoreactive neurons in the paraventricular nucleus of the hypothalamus and in the nucleus of the solitary tract of the brainstem. Regul Pept 157 (2009) 84-91
74. Mönnikes H., Lauer G., and Arnold R. Peripheral adminsitration of cholecystokinin activates c-fos expression int he locus coeruleus/subcoerular, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat. Brain Res 770 (1997) 277-288
75. Szelényi Z., Zeisberger E., and Brück K. A hypothalamic alpha-adrenergic mechanism mediating the thermogenic response to electrical stimulation of the lower brainstem in the guinea-pig. Pflügers Arch 370 (1977) 19-23
76. Ge J., Long S.K., and Kilpatrick I.C. Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,206, in rat brain. Eur J Pharmacol 345 (1998) 163-170
77. Shinohara S., and Kawasaki K. Electrophysiological changes in rat hippocampal pyramidal neurons produced by cholecystokinin octapeptide. Neurosciences 78 (1997) 1005-1016
78. Szelényi Z., Székely M., and Czippán L. Autonomic cold- and heat-defence of rats during a febrile rise in core temperature induced by intracerebroventricular infusion of prostaglandin E1. Pathophysiology 3 (1996) 219-226
79. Feng J.D., Price M., Cohen J., and Satinoff E. Prostaglandin fevers in rats: regulated change in body temperature or change in regulated body temperature. Am J Physiol 257 (1989) R695-R699
80. de Krom M., van der Schouw Y.T., Hendriks J., et al. Common genetic variations in CCK, leptin and leptin receptor genes are associated with specific human eating patterns. Diabetes 56 (2007) 276-280